Improving Access to Care for Veterans With Memory Loss

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-29

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advanced diagnostics, and streamlined workflows to expedite screening for eligibility for amyloid targeting therapies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Online Caregiver Psychoeducation and Support for Alzheimer's

NCT00416078

Alzheimer's Disease

COMPLETED PHASE2/PHASE3

VIdeo Telehealth in ALzheimer's: NeuroPsychology (VITAL-NP)

NCT05379023

Suspected Typical Alzheimer's Disease (AD) Suspected Atypical Alzheimer's Disease (AD)

COMPLETED NA

REACH Hope Intervention for Dementia and TBI Caregivers

NCT04969796

Dementia, Mixed Dementia of Alzheimer Type TBI (Traumatic Brain Injury)

UNKNOWN NA

Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease

NCT06856681

Alzheimers Disease

WITHDRAWN NA

Remote Sensing for ADRD-Specific Activities Identification in Older Adults

NCT07120347

Alzheimer Disease and Related Dementias (ADRD) Mild Cognitive Impairment (MCI)

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ADRD Care Delivery Protocol

Patients will undergo telehealth preparedness assessment, cognitive screening, and blood biomarker testing prior to the initial consultation with the specialist.

Group Type EXPERIMENTAL

ADRD Care Delivery Protocol

Intervention Type OTHER

1\. Included in arm/group descriptions

Usual Care

Patients will undergo usual care with all evaluation and testing at the discretion of the specialist.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ADRD Care Delivery Protocol

1\. Included in arm/group descriptions

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of mild cognitive impairment or mild dementia due to suspected or confirmed AD with a 5 minute telephone MoCA score \>7

Exclusion Criteria

* Enrolled in VA care
* Lives in a home setting (i.e., not in an institutional setting such as a nursing home, Community Living Center, or hospital)
* Has a working telephone
* 18 years and older
* Able to communicate in English
* Willing to give informed consent.

* None

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No